Consolidated Balance Sheets (in millions) |
December 31, 2015 |
December 31, 2014 |
Assets |
|
|
Cash and cash equivalents |
$1,516.6 |
$1,108.6 |
Investments |
4,766.3 |
5,347.1 |
Accounts receivable |
2,645.7 |
2,537.6 |
Property and equipment, net |
1,752.2 |
1,628.8 |
Goodwill and other intangible assets, net |
842.3 |
833.1 |
Other assets |
1,626.4 |
1,398.1 |
Total assets |
$13,149.5 |
$12,853.3 |
Liabilities and Net Assets |
|
|
Claims outstanding |
$2,908.5 |
$2,391.5 |
Unearned premium revenue |
291.9 |
300.5 |
Amounts held for others |
500.7 |
488.6 |
Benefit plan liabilities |
870.1 |
811.6 |
Debt |
1,714.6 |
1,703.7 |
Other liabilities |
1,700.1 |
1,746.4 |
Total liabilities |
7,985.9 |
7,442.3 |
Total net assets |
5,163.6 |
5,411.0 |
Total liabilities and net assets |
$13,149.5 |
$12,853.3 |
Consolidated Statements of Operations (in millions) |
Years Ended December 31, |
2015 |
2014 |
Premium and management services revenue |
$14,116.1 |
$13,664.4 |
Net patient service revenue |
1,854.3 |
1,646.0 |
Vision and other revenue |
1,696.5 |
1,440.9 |
Total unrestricted revenue |
17,666.9 |
16,751.3 |
Claims incurred |
11,423.2 |
10,641.6 |
Depreciation and amortization |
300.2 |
288.8 |
Other operating expense |
6,489.5 |
6,015.3 |
Change in premium deficiency reserves |
19.0 |
(16.4) |
Total expenses |
18,231.9 |
16,929.3 |
Operating loss |
(565.0) |
(178.0) |
Net investment income |
294.1 |
253.8 |
Interest expense |
(60.6) |
(62.8) |
Nonoperating income (expenses) |
5.4 |
(3.3) |
(Deficit) excess of revenue over expenses before merger |
(326.1) |
9.7 |
Net assets acquired through merger |
249.3 |
|
(Deficit) excess of revenue over expenses before income taxes |
(76.8) |
9.7 |
Income tax provision |
7.9 |
92.7 |
Deficit of revenue over expenses |
$(84.7) |
$(83.0) |
Consolidated Statements of Cash Flows (in millions) |
Years Ended December 31, |
2015 |
2014 |
Net cash provided by (used in) operating activities |
$22.1 |
$(267.2) |
Net cash provided by investing activities |
478.6 |
65.4 |
Net cash (used in) provided by financing activities |
(92.7) |
35.9 |
Increase (decrease) in cash and cash equivalents |
408.0 |
(165.9) |
Cash and cash equivalents, Beginning of year |
1,108.6 |
1,274.5 |
Cash and cash equivalents, End of year |
$1,516.6 |
$1,108.6 |
|
|
|
Read our financial overview.